HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GLYCOPROTEIN 120-SPECIFIC T-LYMPHOCYTES PROVIDE INTERMOLECULAR HELP FOR ANTI-CD4 AUTOANTIBODY PRODUCTION IN EXPOSED UNINFECTED SUBJECTS
L. Furci et al., HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GLYCOPROTEIN 120-SPECIFIC T-LYMPHOCYTES PROVIDE INTERMOLECULAR HELP FOR ANTI-CD4 AUTOANTIBODY PRODUCTION IN EXPOSED UNINFECTED SUBJECTS, AIDS research and human retroviruses, 13(17), 1997, pp. 1461-1469
Anti-CD4 antibodies have been documented in about 10-20% of HIV-infect
ed patients, This autoimmune response could be triggered by increased
CD4 processing and unveiling of hidden (cryptic) epitopes, Multiple ma
rkers of exposure to HIV have been described in exposed uninfected ind
ividuals, Here, we investigated the mechanisms underlying the generati
on of anti-CD4 antibodies in a cohort of 54 seronegative exposed uninf
ected individuals, We identified anti-CD4 antibodies above normal leve
ls in 16 of 47 (34%) exposed uninfected subjects, The fine specificity
of these antibodies was different in this cohort when compared with t
hose found in HIV+ patients, This suggested the possibility of differe
nt mechanisms underlying the generation of anti-CD4 antibodies in thes
e two groups. Indeed, in exposed uninfected subjects, we found circula
ting CD4 T cells specific for gp120, but not for CD4. In contrast, HIV
-l-seropositive patients had peripheral blood T cells specific for bot
h molecules, Noncovalent binding of gp120 to soluble CD4 enhanced acti
vation of gp120-specific T lymphocytes in exposed uninfected subjects,
but not in HIV+ subjects, Moreover, gp120-specific T cells isolated f
rom exposed uninfected, but not from HIV+, subjects provided help for
anti-CD4 antibody production by B cells pulsed with CD4-gp120 complex,
We conclude that gp120-specific T cells are present in exposed uninfe
cted individuals, and can provide intermolecular help for anti-CD4 ant
ibody production, This mechanism is distinct from that found in HIV-l-
seropositive patients and may play a protective role against HIV-1 inf
ection in vivo.